Arrowhead to Report Fiscal 2014 First Quarter Financial Results
Conference Call Scheduled for Tuesday, February 4, 2014
PASADENA, Calif. -- January 28, 2014
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company
developing targeted RNAi therapeutics, today announced that it will report its
financial results for the fiscal 2014 first quarter ended December 31, 2013,
on Tuesday, February 4, 2014, at 4:30 p.m. Eastern time. To participate in the
conference call, please dial 877-300-8521 (toll free from the US),
855-669-9657 (toll free from Canada), or 412-317-6026 (for international
callers). Investors may also access a live audio webcast of this conference
call on the Company's website at
A replay of the webcast will be available approximately one hour after the
conclusion of the call and will remain available for 90 days. An audio replay
will also be available approximately two hours after the conclusion of the
call and will be available for 30 days. The audio replay can be accessed by
dialing 877-870-5176 (toll free from the US and Canada), or 858-384-5517 (for
international callers) and entering Event ID 10040388.
About Arrowhead Research Corporation
Arrowhead Research Corporation is a biopharmaceutical company developing
targeted RNAi therapeutics. The company is leveraging its proprietary drug
delivery technologies to develop targeted drugs based on the RNA interference
mechanism that efficiently silence disease-causing genes. Arrowhead
technologies also enable partners to create peptide-drug conjugates that
specifically home to cell types of interest while sparing off-target tissues.
Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus
and partner-based programs in obesity and oncology.
For more information please visit http://www.arrowheadresearch.com, or follow
us on Twitter @ArrowRes. To be added to the Company's email list to receive
news directly, please send an email to email@example.com.
Arrowhead Research Corporation
Vince Anzalone, CFA
The Trout Group
Press spacebar to pause and continue. Press esc to stop.